TearClear

TearClear is a small, emerging pharmaceutical company located in Los Angeles, California. Founded with a mission to revolutionize topical medication delivery for the eye, TearClear employs a team of three dedicated professionals. The company focuses on developing ophthalmic pharmaceutical products, with a primary emphasis on glaucoma treatment. TearClear's lead product candidates aim to address the limitations of existing topical medications by utilizing a unique platform that enhances patient safety and compliance. This innovative approach seeks to capture preservatives before they reach the ocular surface, potentially creating a safer and more effective treatment experience. TearClear's commitment to innovation and patient well-being sets them apart in the ophthalmic pharmaceutical landscape. Their research and development efforts are focused on creating first-in-class drugs that address unmet needs in glaucoma treatment and explore future applications across various ocular conditions. To learn more about TearClear and their groundbreaking approach to ophthalmic pharmaceuticals, visit their website at tearclear.com.